"Every step, every patient we treat in our cancer trials helps us to find out more about what we are against and how to address that," Prof Tureci, BioNTech's chief medical officer, said.
Caution is needed. Many promising cancer trials end in failure. It may be several years before we know if BioNTech's treatments for bowel cancer, melanoma and other tumour types really do live up to the hype.There is no doubt though that Covid mRNA vaccines have been highly successful and made billions for BioNTech, Pfizer and Moderna.US firm Moderna hasProf Sahin, BioNTech's chief executive officer, says the company will vigorously defend against the allegations.
Cancer is a big separate business, more charity donations, more cancer. Ask Cancer Research PackItIn
Nope...it exasperates existing cancer. Look at the data.
Nein!